- Cannabis stock Canopy Growth unveiled a new line of products from several of its brands
- New product offerings include Tweed softgels and oils featuring minor cannabinoids, a large format flower offering from Tweed, as well as new medical exclusive pre-roll products from 7ACRES and Spectrum Therapeutics
- Tweed also introduced four new products featuring CBD and minor cannabinoids in oil and softgel formats
- Canopy Growth stock opened Wednesday trading at C$6.32 per share
Cannabis stock Canopy Growth (TSX:WEED; NDAQ:CGC) unveiled a new line of products from several of its brands.
The Canadian multinational cannabis company rolled out new product offerings across its adult use and medical cannabis portfolio, including new Tweed softgels and oils featuring minor cannabinoids, a large format flower offering from Tweed, as well as new medical exclusive pre-roll products from 7ACRES and Spectrum Therapeutics.
Fresh on the shelves
Tweed Lemon Meringue Pie flower comes in a 28g package, packed with sativa whole cannabis flower that has been derived from the Lemon Skunk and Cookies ‘n’ Cream lineage, it features terpenes a-Pinene, Myrcene and Limonene.
7ACRES Jack Haze pre-rolled joints feature a range of 17 per cent to 23 per cent THC and a max CBD potency of 25 per cent, 7ACRES Jack Haze was the result of a large-scale genetic selection program with the goal of finding this novel sativa expression. This phenotype stood out among the rest.
For medical cannabis customers, Spectrum Therapeutics is extending its Spectrum Reserve collection with Alien Breath and (GG#4 x Mendo Breath) pre-roll joints.
Tweed introduces products featuring CBD and minor cannabinoids in oil and softgel formats
These four new products are:
- Tweed CBD:CBG 4:1 Oil, a newly formulated cannabis oil that is designed to pair with well-being focused daily routines and provides 100 mg/g CBD and 25 mg/g CBG
- Tweed CBD:CBG 6:1 Softgels is available with 30 softgels per bottle each containing 60 mg of CBD and 10 mg CBG
- Tweed CBD:CBN 4:1 Oil is designed to become part of a nightly routine and delivers 100 mg/g CBD and 25 mg/g CBN
- Tweed CBD:CBN 6:1Softgels is available with 30 softgels per bottle each containing 60 mg of CBD and 10 mg CBN
“In addition to launching new flower products, we’re making it easier to access CBD and minor cannabinoids in convenient oil and softgel formats to support wellness-minded consumers looking to start the year feeling their best,” Canopy Growth’s president, Dave Paterson, said in a statement. “For our medical cannabis consumers, we’re proud to continue delivering the variety and convenience that the Spectrum Therapeutics store is synonymous for thanks to new pre-rolls from 7ACRES and the Spectrum Reserve.”
Canopy Growth is a North American cannabis and consumer packaged goods company. Its brands include Doja, 7ACRES, Tweed, Deep Space, Martha Stewart CBD and Storz & Bickel.
The Smith Falls, Ontario-based company has positioned itself to capitalize on U.S. cannabis legalization through its rights to Acreage Holdings, a vertically integrated multi-state cannabis operator, Wana Brands, a cannabis edibles brand, and Jetty Extracts, a producer of cannabis extracts and a pioneer of clean vape technology.
Canopy Growth stock opened Wednesday trading at C$6.32 per share, a loss of 0.16 per cent from the previous session. The stock has fallen nearly 83 per cent year-over-year and 99 per cent since 2019.
Join the discussion: Find out what everybody’s saying about this cannabis stock on the Canopy Growth Bullboard, and check out the rest of Stockhouse’s stock forums and message boards.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.